DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY), AbbVie Inc (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ)

Three years after Pfizer Inc. (NYSE:PFE) dropped a bombshell on its plans to lay off more than 1000 workers. The biopharmaceutical company has come back with some of the best news, on how it plans to use the vacated Groton site. In a joint announcement, Gov. Dannel P. Malloy and Pfizer confirmed that two buildings on the company’s campus will be donated for use in … Continue reading DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY), AbbVie Inc (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ)

Chris Lewis04/0404/04

Trader’s Alert: AbbVie Inc (NYSE:ABBV), NeoStem Inc (NASDAQ:NBS), Occidental Petroleum Corporation (NYSE:OXY), Wells Fargo & Co (NYSE:WFC)

AbbVie, Inc. (NYSE:ABBV) announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, an area of unmet need. Currently there are no approved treatments for fingernail psoriasis. AbbVie Inc (NYSE:ABBV) stock performance was 1.07% in last session and finished the day at … Continue reading Trader’s Alert: AbbVie Inc (NYSE:ABBV), NeoStem Inc (NASDAQ:NBS), Occidental Petroleum Corporation (NYSE:OXY), Wells Fargo & Co (NYSE:WFC)

Jason Knox03/2103/21

Market Movers: AbbVie Inc. (NYSE:ABBV), Morgan Stanley (NYSE:MS), Sanmina Corporation (NASDAQ:SANM), Advanced Semiconductor Engineering Inc. (NYSE:ASX), Resource Capital Corp. (NYSE:RSO)

AbbVie Inc. (NYSE:ABBV) rival Gilead makes exclusive deal with CVS for hep C drugs. The deal blocks North Chicago-based AbbVie Inc.’s treatment, called Viekira Pak, which will only be available to patients given approval because of medical exceptions or through a process called prior authorization, according to CVS. Patients already taking Viekira Pak will be allowed to finish their treatment. AbbVie Inc. (NYSE:ABBV) belongs to … Continue reading Market Movers: AbbVie Inc. (NYSE:ABBV), Morgan Stanley (NYSE:MS), Sanmina Corporation (NASDAQ:SANM), Advanced Semiconductor Engineering Inc. (NYSE:ASX), Resource Capital Corp. (NYSE:RSO)

Richard Atkins01/0801/08

Trader’s Buzz: AbbVie Inc. (NYSE:ABBV), Twenty-First Century Fox, Inc. (NASDAQ:FOXA), Brunswick Corporation (NYSE:BC), Cheniere Energy, Inc. (NYSEMKT:LNG), Forward Industries Inc. (NASDAQ:FORD)

On Dec. 23, AbbVie (NYSE:ABBV) will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Tuesday, Jan. 6, 2015. Richard A. Gonzalez, chairman and chief executive officer, will take part in a question and answer session at 2:15 p.m. Central time. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 18.90% and weekly performance is -1.38%. On last trading day company … Continue reading Trader’s Buzz: AbbVie Inc. (NYSE:ABBV), Twenty-First Century Fox, Inc. (NASDAQ:FOXA), Brunswick Corporation (NYSE:BC), Cheniere Energy, Inc. (NYSEMKT:LNG), Forward Industries Inc. (NASDAQ:FORD)

Kristen Barton12/29

Top Wall Street Stories: Wells Fargo & Company (NYSE:WFC), AbbVie Inc. (NYSE:ABBV), Sigma-Aldrich Corporation (NASDAQ:SIAL), Sanofi SA (ADR) (NYSE:SNY), Sprint Corporation (NYSE:S)

Wells Fargo & Company (NYSE:WFC)’s Wealth, Brokerage and Retirement (WBR) division today announced the launch of Wells Fargo Investment Institute (WFII). WFII brings together the investment research, strategy, manager research and publications teams from WBR’s four lines of business to create a single group with a goal of providing world-class advice to the company’s financial and wealth advisors and clients. Wells Fargo & Company (NYSE:WFC) … Continue reading Top Wall Street Stories: Wells Fargo & Company (NYSE:WFC), AbbVie Inc. (NYSE:ABBV), Sigma-Aldrich Corporation (NASDAQ:SIAL), Sanofi SA (ADR) (NYSE:SNY), Sprint Corporation (NYSE:S)

Kristen Barton12/08

Stocks Swings: AbbVie Inc. (NYSE:ABBV), Yelp, Inc. (NYSE:YELP), Universal Health Services Inc. (NYSE:UHS), Tompkins Financial Corporation (NYSEMKT:TMP), Walgreen Co. (NYSE:WAG)

AbbVie (NYSE:ABBV) said that it presented new results from a Phase 2 study of investigational compound venetoclax (ABT-199/GDC-0199) in patients with acute myelogenous leukemia or AML at the 56th American Society of Hematology Annual Meeting. AbbVie Inc. (NYSE:ABBV) belongs to Healthcare sector. Its net profit margin is 18.90% and weekly performance is 0.74%. On last trading day company shares ended up $69.71. AbbVie Inc. (NYSE:ABBV) … Continue reading Stocks Swings: AbbVie Inc. (NYSE:ABBV), Yelp, Inc. (NYSE:YELP), Universal Health Services Inc. (NYSE:UHS), Tompkins Financial Corporation (NYSEMKT:TMP), Walgreen Co. (NYSE:WAG)

Kevin Long12/08